Amedeo Smart

Free Medical Literature Service


 

Amedeo

COVID-19

  Free Subscription

Articles published in
Life Sci
    August 2021
  1. LUTHRA R, Kaur S, Bhandari K
    Applications of CRISPR as a potential therapeutic.
    Life Sci. 2021 Aug 25:119908. doi: 10.1016/j.lfs.2021.119908.
    >> Share

  2. PAL D, Goyal J, Sharma U, Sharma A, et al
    Mesenchymal stem cells in SARS-CoV-2 infection: A hype or hope.
    Life Sci. 2021;284:119901.
    >> Share

  3. AMRUTA N, Engler-Chiurazzi EB, Murray-Brown IC, Gressett TE, et al
    In Vivo protection from SARS-CoV-2 infection by ATN-161 in k18-hACE2 transgenic mice.
    Life Sci. 2021;284:119881.
    >> Share

    June 2021
  4. ADITYA RAO SJ, Shetty NP
    Evolutionary selectivity of amino acid is inspired from the enhanced structural stability and flexibility of the folded protein.
    Life Sci. 2021 Jun 28:119774. doi: 10.1016/j.lfs.2021.119774.
    >> Share

  5. CHAN Y, Ng SW, Singh SK, Gulati M, et al
    Revolutionizing polymer-based nanoparticle-linked vaccines for targeting respiratory viruses: A perspective.
    Life Sci. 2021;280:119744.
    >> Share

  6. LEE MC, Chen YK, Tsai-Wu JJ, Hsu YJ, et al
    Zinc supplementation augments the suppressive effects of repurposed NF-kappaB inhibitors on ACE2 expression in human lung cell lines.
    Life Sci. 2021;280:119752.
    >> Share

    May 2021
  7. KARSLI E, Sabirli R, Altintas E, Canacik O, et al
    Soluble P-selectin as a potential diagnostic and prognostic biomarker for COVID-19 disease: A case-control study.
    Life Sci. 2021 May 17:119634. doi: 10.1016/j.lfs.2021.119634.
    >> Share

  8. CHATTERJEE S, Mishra S, Chowdhury KD, Ghosh CK, et al
    Various theranostics and immunization strategies based on nanotechnology against Covid-19 pandemic: An interdisciplinary view.
    Life Sci. 2021 May 12:119580. doi: 10.1016/j.lfs.2021.119580.
    >> Share

  9. OKUYAN HM, Dogan S, Bal T, Cabalak M, et al
    Beclin-1, an autophagy-related protein, is associated with the disease severity of COVID-19.
    Life Sci. 2021 May 10:119596. doi: 10.1016/j.lfs.2021.119596.
    >> Share

    April 2021
  10. DAWRE S, Maru S
    Human respiratory viral infections: Current status and future prospects of nanotechnology-based approaches for prophylaxis and treatment.
    Life Sci. 2021 Apr 26:119561. doi: 10.1016/j.lfs.2021.119561.
    >> Share

  11. GHAEBI M, Tahmasebi S, Jozghorbani M, Sadeghi A, et al
    Risk factors for adverse outcomes of COVID-19 patients: Possible basis for diverse responses to the novel coronavirus SARS-CoV-2.
    Life Sci. 2021;277:119503.
    >> Share

  12. CHEUDJEU A
    Antiviral strategies should focus on stimulating the biosynthesis of heparan sulfates, not their inhibition.
    Life Sci. 2021;277:119508.
    >> Share

  13. PARIS GC, de A Azevedo A, Ferreira AL, de A Azevedo YM, et al
    Therapeutic potential of mesenchymal stem cells in multiple organs affected by COVID-19.
    Life Sci. 2021 Apr 15:119510. doi: 10.1016/j.lfs.2021.119510.
    >> Share

    March 2021
  14. TAHMASEBI S, Saeed BQ, Temirgalieva E, Yumashev AV, et al
    Nanocurcumin improves Treg cell responses in patients with mild and severe SARS-CoV2.
    Life Sci. 2021 Mar 28:119437. doi: 10.1016/j.lfs.2021.119437.
    >> Share

  15. PRASANNA P, Rathee S, Upadhyay A, Sulakshana S, et al
    Nanotherapeutics in the treatment of acute respiratory distress syndrome.
    Life Sci. 2021;276:119428.
    >> Share

  16. POTJE SR, Costa TJ, Fraga-Silva TFC, Martins RB, et al
    Heparin prevents in vitro glycocalyx shedding induced by plasma from COVID-19 patients.
    Life Sci. 2021;276:119376.
    >> Share

  17. POSADAS-SANCHEZ R, Sanchez-Munoz F, Guzman-Martin CA, Hernandez-Diaz Couder A, et al
    Dipeptidylpeptidase-4 levels and DPP4 gene polymorphisms in patients with COVID-19. Association with disease and with severity.
    Life Sci. 2021;276:119410.
    >> Share

  18. CHENG X, Xin S, Chen Y, Li L, et al
    Effects of metformin, insulin on COVID-19 patients with pre-existed type 2 diabetes: A multicentral retrospective study.
    Life Sci. 2021;275:119371.
    >> Share

  19. DIMBATH E, Maddipati V, Stahl J, Sewell K, et al
    Implications of microscale lung damage for COVID-19 pulmonary ventilation dynamics: A narrative review.
    Life Sci. 2021;274:119341.
    >> Share

  20. HASSANZADEH P
    The significance of bioengineered nanoplatforms against SARS-CoV-2: From detection to genome editing.
    Life Sci. 2021 Mar 4:119289. doi: 10.1016/j.lfs.2021.119289.
    >> Share

    February 2021
  21. CHIAPPALUPI S, Salvadori L, Vukasinovic A, Donato R, et al
    Targeting RAGE to prevent SARS-CoV-2-mediated multiple organ failure: Hypotheses and perspectives.
    Life Sci. 2021 Feb 23:119251. doi: 10.1016/j.lfs.2021.119251.
    >> Share

  22. SANTIESTEBAN-LORES LE, Amamura TA, da Silva TF, Midon LM, et al
    A double edged-sword - The Complement System during SARS-CoV-2 infection.
    Life Sci. 2021;272:119245.
    >> Share

  23. KUNNUMAKKARA AB, Rana V, Parama D, Banik K, et al
    COVID-19, cytokines, inflammation, and spices: How are they related?
    Life Sci. 2021 Feb 16:119201. doi: 10.1016/j.lfs.2021.119201.
    >> Share

  24. SAVIRON-CORNUDELLA R, Villalba A, Esteban LM, Tajada M, et al
    Screening of severe acute respiratory syndrome coronavirus-2 infection during labor and delivery using polymerase chain reaction and immunoglobulin testing.
    Life Sci. 2021 Feb 9:119200. doi: 10.1016/j.lfs.2021.119200.
    >> Share

    January 2021
  25. AGHBASH PS, Eslami N, Shamekh A, Entezari-Maleki T, et al
    SARS-CoV-2 infection: The role of PD-1/PD-L1 and CTLA-4 axis.
    Life Sci. 2021;270:119124.
    >> Share

  26. WANG SC, Wang YF
    Cardiovascular protective properties of oxytocin against COVID-19.
    Life Sci. 2021 Jan 26:119130. doi: 10.1016/j.lfs.2021.119130.
    >> Share

  27. ABID SA, Suhail A, Al-Kadmy IMS, Sattar AA, et al
    Biosensors as a future diagnostic approach for COVID-19.
    Life Sci. 2021 Jan 25:119117. doi: 10.1016/j.lfs.2021.119117.
    >> Share

  28. MANSOUR BS, Salem NA, Kader GA, Abdel-Alrahman G, et al
    Protective effect of Rosuvastatin on Azithromycin induced cardiotoxicity in a rat model.
    Life Sci. 2021;269:119099.
    >> Share

  29. FAWAD M, Mubarik S, Malik SS, Ren J, et al
    Statistical analysis of COVID-19 infection caused by environmental factors: Evidence from Pakistan.
    Life Sci. 2021 Jan 18:119093. doi: 10.1016/j.lfs.2021.119093.
    >> Share

  30. MEIDANINIKJEH S, Sabouni N, Marzouni HZ, Bengar S, et al
    Monocytes and macrophages in COVID-19: Friends and foes.
    Life Sci. 2021;269:119010.
    >> Share

  31. HAROUN RA, Osman WH, Eessa AM
    Interferon-gamma-induced protein 10 (IP-10) and serum amyloid A (SAA) are excellent biomarkers for the prediction of COVID-19 progression and severity.
    Life Sci. 2021 Jan 14:119019. doi: 10.1016/j.lfs.2021.119019.
    >> Share

  32. ZHANG Z, Wang T, Liu F, Zhu A, et al
    The proteomic characteristics of airway mucus from critical ill COVID-19 patients.
    Life Sci. 2021;269:119046.
    >> Share

    December 2020
  33. KOTNALA S, Dhasmana A, Kashyap VK, Chauhan SC, et al
    A bird eye view on cystic fibrosis: An underestimated multifaceted chronic disorder.
    Life Sci. 2020 Dec 28:118959. doi: 10.1016/j.lfs.2020.118959.
    >> Share

  34. HIRAWAT R, Saifi MA, Godugu C
    Targeting inflammatory cytokine storm to fight against COVID-19 associated severe complications.
    Life Sci. 2020;267:118923.
    >> Share

  35. SILVEIRA MM, Moreira GMSG, Mendonca M
    DNA vaccines against COVID-19: Perspectives and challenges.
    Life Sci. 2020 Dec 19:118919. doi: 10.1016/j.lfs.2020.118919.
    >> Share

  36. P KM, Sivashanmugam K, Kandasamy M, Subbiah R, et al
    Repurposing of histone deacetylase inhibitors: A promising strategy to combat pulmonary fibrosis promoted by TGF-beta signalling in COVID-19 survivors.
    Life Sci. 2020;266:118883.
    >> Share

  37. LU J, Hou Y, Ge S, Wang X, et al
    Screened antipsychotic drugs inhibit SARS-CoV-2 binding with ACE2 in vitro.
    Life Sci. 2020;266:118889.
    >> Share

    November 2020
  38. LA MARCA G, Barp J, Frenos S, Mugelli A, et al
    Thermal inactivation of SARS COVID-2 virus: Are steam inhalations a potential treatment?
    Life Sci. 2020 Nov 21:118801. doi: 10.1016/j.lfs.2020.118801.
    >> Share

  39. SABIRLI R, Koseler A, Goren T, Turkcuer I, et al
    High GRP78 levels in Covid-19 infection: A case-control study.
    Life Sci. 2020 Nov 18:118781. doi: 10.1016/j.lfs.2020.118781.
    >> Share

  40. LANG Y, Chen K, Li Z, Li H, et al
    The nucleocapsid protein of zoonotic betacoronaviruses is an attractive target for antiviral drug discovery.
    Life Sci. 2020 Nov 12:118754. doi: 10.1016/j.lfs.2020.118754.
    >> Share

    October 2020
  41. DHAUNDIYAL A, Kumari P, Jawalekar SS, Chauhan G, et al
    Is highly expressed ACE 2 in pregnant women "a curse" in times of COVID-19 pandemic?
    Life Sci. 2020 Oct 28:118676. doi: 10.1016/j.lfs.2020.118676.
    >> Share

  42. SHRESTHA DB, Budhathoki P, Syed NI, Rawal E, et al
    Remdesivir: A potential game-changer or just a myth? A systematic review and meta-analysis.
    Life Sci. 2020 Oct 26:118663. doi: 10.1016/j.lfs.2020.118663.
    >> Share

  43. BAKADIA BM, Boni BOO, Ahmed AAQ, Yang G, et al
    The impact of oxidative stress damage induced by the environmental stressors on COVID-19.
    Life Sci. 2020 Oct 26:118653. doi: 10.1016/j.lfs.2020.118653.
    >> Share

  44. PAN ZY, Chang YX, Han N, Hou FY, et al
    Short-term high-dose gavage of hydroxychloroquine changes gut microbiota but not the intestinal integrity and immunological responses in mice.
    Life Sci. 2020 Oct 22:118450. doi: 10.1016/j.lfs.2020.118450.
    >> Share

  45. MORRIS G, Bortolasci CC, Puri BK, Olive L, et al
    Preventing the development of severe CoVID 19 by modifying immunothrombosis.
    Life Sci. 2020 Oct 20:118617. doi: 10.1016/j.lfs.2020.118617.
    >> Share

  46. BAILLY C, Vergoten G
    Mechanistic insights into dimethyl cardamonin-mediated pharmacological effects: A double control of the AMPK-HMGB1 signaling axis.
    Life Sci. 2020 Oct 18:118601. doi: 10.1016/j.lfs.2020.118601.
    >> Share

  47. YADAV P, Vats R, Bano A, Bhardwaj R, et al
    Mesenchymal stem cell immunomodulation and regeneration therapeutics as an ameliorative approach for COVID-19 pandemics.
    Life Sci. 2020;263:118588.
    >> Share

  48. SATARKER S, Nampoothiri M
    Involvement of the nervous system in COVID-19: The bell should toll in the brain.
    Life Sci. 2020 Oct 6:118568. doi: 10.1016/j.lfs.2020.118568.
    >> Share

  49. MORRIS G, Athan E, Walder K, Bortolasci CC, et al
    Can endolysosomal deacidification and inhibition of autophagy prevent severe COVID-19?
    Life Sci. 2020;262:118541.
    >> Share

    September 2020
  50. VITIELLO A, Ferrara F
    Pharmacological agents to therapeutic treatment of cardiac injury caused by Covid-19.
    Life Sci. 2020;262:118510.
    >> Share

  51. PENG W, Wu H, Tan Y, Li M, et al
    Mechanisms and treatments of myocardial injury in patients with corona virus disease 2019.
    Life Sci. 2020;262:118496.
    >> Share

  52. SADEGHI S, Soudi S, Shafiee A, Hashemi SM, et al
    Mesenchymal stem cell therapies for COVID-19: Current status and mechanism of action.
    Life Sci. 2020;262:118493.
    >> Share

  53. UNUDURTHI SD, Luthra P, Bose RJC, McCarthy J, et al
    Cardiac inflammation in COVID-19: Lessons from heart failure.
    Life Sci. 2020 Sep 21:118482. doi: 10.1016/j.lfs.2020.118482.
    >> Share

  54. BELHASSAN A, En-Nahli F, Zaki H, Lakhlifi T, et al
    Assessment of effective imidazole derivatives against SARS-CoV-2 main protease through computational approach.
    Life Sci. 2020 Sep 18:118469. doi: 10.1016/j.lfs.2020.118469.
    >> Share

  55. VINAYAGAM S, Sattu K
    SARS-CoV-2 and coagulation disorders in different organs.
    Life Sci. 2020;260:118431.
    >> Share

  56. KHATRI R, Gupta RK, Vats P, Bansal V, et al
    Subclinical elevated B-type Natriuretic Peptide (BNP) indicates endothelial dysfunction contributing to hypoxia susceptibility in healthy individuals.
    Life Sci. 2020 Sep 11:118408. doi: 10.1016/j.lfs.2020.118408.
    >> Share

  57. CHAUDHRY SN, Hazafa A, Mumtaz M, Kalsoom U, et al
    New insight on possible vaccine development against SARS-CoV-2.
    Life Sci. 2020 Sep 11:118421. doi: 10.1016/j.lfs.2020.118421.
    >> Share

  58. DUERR GD, Heine A, Hamiko M, Zimmer S, et al
    Parameters predicting COVID-19-induced myocardial injury and mortality.
    Life Sci. 2020 Sep 9:118400. doi: 10.1016/j.lfs.2020.118400.
    >> Share

    August 2020
  59. CACCIAPUOTI S, De Rosa A, Gelzo M, Megna M, et al
    Immunocytometric analysis of COVID patients: A contribution to personalized therapy?
    Life Sci. 2020 Aug 29:118355. doi: 10.1016/j.lfs.2020.118355.
    >> Share

  60. CHEUDJEU A
    Correlation of D-xylose with severity and morbidity-related factors of COVID-19 and possible therapeutic use of D-xylose and antibiotics for COVID-19.
    Life Sci. 2020;260:118335.
    >> Share

  61. WANG F, Zheng S, Zheng C, Sun X, et al
    Attaching clinical significance to COVID-19-associated diarrhea.
    Life Sci. 2020;260:118312.
    >> Share

  62. BHAVANA V, Thakor P, Singh SB, Mehra NK, et al
    COVID-19: Pathophysiology, treatment options, nanotechnology approaches, and research agenda to combating the SARS-CoV2 pandemic.
    Life Sci. 2020 Aug 23:118336. doi: 10.1016/j.lfs.2020.118336.
    >> Share

  63. ELFIKY AA, Baghdady AM, Ali SA, Ahmed MI, et al
    GRP78 targeting: Hitting two birds with a stone.
    Life Sci. 2020 Aug 22:118317. doi: 10.1016/j.lfs.2020.118317.
    >> Share

  64. VARGAS-ALARCON G, Posadas-Sanchez R, Ramirez-Bello J
    Variability in genes related to SARS-CoV-2 entry into host cells (ACE2, TMPRSS2, TMPRSS11A, ELANE, and CTSL) and its potential use in association studies.
    Life Sci. 2020;260:118313.
    >> Share

  65. PARVATHANENI V, Gupta V
    Utilizing drug repurposing against COVID-19 - Efficacy, limitations, and challenges.
    Life Sci. 2020 Aug 17:118275. doi: 10.1016/j.lfs.2020.118275.
    >> Share

  66. HOSSEINI FS, Amanlou M
    Anti-HCV and anti-malaria agent, potential candidates to repurpose for coronavirus infection: Virtual screening, molecular docking, and molecular dynamics simulation study.
    Life Sci. 2020;258:118205.
    >> Share

  67. MAHENDIRATTA S, Batra G, Sarma P, Kumar H, et al
    Molecular diagnosis of COVID-19 in different biologic matrix, their diagnostic validity and clinical relevance: A systematic review.
    Life Sci. 2020;258:118207.
    >> Share

  68. MOHAMMAD A, Marafie SK, Alshawaf E, Abu-Farha M, et al
    Structural analysis of ACE2 variant N720D demonstrates a higher binding affinity to TMPRSS2.
    Life Sci. 2020 Aug 5:118219. doi: 10.1016/j.lfs.2020.118219.
    >> Share

  69. DAS S, Anu KR, Birangal SR, Nikam AN, et al
    Role of comorbidities like diabetes on severe acute respiratory syndrome coronavirus-2: A review.
    Life Sci. 2020 Aug 3:118202. doi: 10.1016/j.lfs.2020.118202.
    >> Share

  70. MANSOURABADI AH, Sadeghalvad M, Mohammadi-Motlagh HR, Rezaei N, et al
    The immune system as a target for therapy of SARS-CoV-2: A systematic review of the current immunotherapies for COVID-19.
    Life Sci. 2020 Aug 1:118185. doi: 10.1016/j.lfs.2020.118185.
    >> Share

    July 2020
  71. MORRIS G, Bortolasci CC, Puri BK, Olive L, et al
    The pathophysiology of SARS-CoV-2: A suggested model and therapeutic approach.
    Life Sci. 2020 Jul 30:118166. doi: 10.1016/j.lfs.2020.118166.
    >> Share

  72. SHARMA K, Morla S, Goyal A, Kumar S, et al
    Computational guided drug repurposing for targeting 2'-O-ribose methyltransferase of SARS-CoV-2.
    Life Sci. 2020 Jul 29:118169. doi: 10.1016/j.lfs.2020.118169.
    >> Share

  73. AKBARI H, Tabrizi R, Lankarani KB, Aria H, et al
    The role of cytokine profile and lymphocyte subsets in the severity of coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis.
    Life Sci. 2020 Jul 28:118167. doi: 10.1016/j.lfs.2020.118167.
    >> Share

  74. SUT BB
    Molecular profiling of immune cell-enriched Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) interacting protein USP13.
    Life Sci. 2020 Jul 28:118170. doi: 10.1016/j.lfs.2020.118170.
    >> Share

  75. ZHANG J, Wang M, Ding W, Wan J, et al
    The interaction of RAAS inhibitors with COVID-19: Current progress, perspective and future.
    Life Sci. 2020;257:118142.
    >> Share

  76. PANIRI A, Akhavan-Niaki H
    Emerging role of IL-6 and NLRP3 inflammasome as potential therapeutic targets to combat COVID-19: Role of lncRNAs in cytokine storm modulation.
    Life Sci. 2020 Jul 18:118114. doi: 10.1016/j.lfs.2020.118114.
    >> Share

  77. ZUCKERBERG J, Shaik M, Nelin TD, Widmeier K, et al
    A lung for all: Novel mechanical ventilator for emergency and low-resource settings.
    Life Sci. 2020 Jul 17:118113. doi: 10.1016/j.lfs.2020.118113.
    >> Share

  78. JAFARZADEH A, Chauhan P, Saha B, Jafarzadeh S, et al
    Contribution of monocytes and macrophages to the local tissue inflammation and cytokine storm in COVID-19: Lessons from SARS and MERS, and potential therapeutic interventions.
    Life Sci. 2020 Jul 17:118102. doi: 10.1016/j.lfs.2020.118102.
    >> Share

  79. JAMWAL S, Gautam A, Elsworth J, Kumar M, et al
    An updated insight into the molecular pathogenesis, secondary complications and potential therapeutics of COVID-19 pandemic.
    Life Sci. 2020 Jul 17:118105. doi: 10.1016/j.lfs.2020.118105.
    >> Share

  80. ABBASIFARD M, Khorramdelazad H
    The bio-mission of interleukin-6 in the pathogenesis of COVID-19: A brief look at potential therapeutic tactics.
    Life Sci. 2020;257:118097.
    >> Share

  81. HAZRA S, Chaudhuri AG, Tiwary BK, Chakrabarti N, et al
    Matrix metallopeptidase 9 as a host protein target of chloroquine and melatonin for immunoregulation in COVID-19: A network-based meta-analysis.
    Life Sci. 2020 Jul 14:118096. doi: 10.1016/j.lfs.2020.118096.
    >> Share

  82. ABDIN SM, Elgendy SM, Alyammahi SK, Alhamad DW, et al
    Tackling the cytokine storm in COVID-19, challenges, and hopes.
    Life Sci. 2020 Jul 11:118054. doi: 10.1016/j.lfs.2020.118054.
    >> Share

  83. BEHL T, Kaur I, Bungau S, Kumar A, et al
    The dual impact of ACE2 in COVID-19 and ironical actions in geriatrics and pediatrics with possible therapeutic solutions.
    Life Sci. 2020;257:118075.
    >> Share

  84. BHARADWAJ S, Lee KE, Dwivedi VD, Kang SG, et al
    Computational insights into tetracyclines as inhibitors against SARS-CoV-2 M(pro) via combinatorial molecular simulation calculations.
    Life Sci. 2020;257:118080.
    >> Share

  85. HAJIVALILI M, Hosseini M, Haji-Fatahaliha M
    Gaining insights on immune responses to the novel coronavirus, COVID-19 and therapeutic challenges.
    Life Sci. 2020 Jul 9:118058. doi: 10.1016/j.lfs.2020.118058.
    >> Share

  86. YAVARPOUR-BALI H, Ghasemi-Kasman M
    Update on neurological manifestations of COVID-19.
    Life Sci. 2020 Jul 8:118063. doi: 10.1016/j.lfs.2020.118063.
    >> Share

  87. STERNBERG A, Naujokat C
    Structural features of coronavirus SARS-CoV-2 spike protein: Targets for vaccination.
    Life Sci. 2020 Jul 6:118056. doi: 10.1016/j.lfs.2020.118056.
    >> Share

    June 2020
  88. BENITEZ-CARDOZA CG, Vique-Sanchez JL
    Potential inhibitors of the interaction between ACE2 and SARS-CoV-2 (RBD), to develop a drug.
    Life Sci. 2020;256:117970.
    >> Share

  89. PANDEY SC, Pande V, Sati D, Upreti S, et al
    Vaccination strategies to combat novel corona virus SARS-CoV-2.
    Life Sci. 2020;256:117956.
    >> Share

  90. HAGE-MELIM LIDS, Federico LB, de Oliveira NKS, Francisco VCC, et al
    Virtual screening, ADME/Tox predictions and the drug repurposing concept for future use of old drugs against the COVID-19.
    Life Sci. 2020;256:117963.
    >> Share

  91. BANU N, Panikar SS, Leal LR, Leal AR, et al
    Protective role of ACE2 and its downregulation in SARS-CoV-2 infection leading to Macrophage Activation Syndrome: Therapeutic implications.
    Life Sci. 2020;256:117905.
    >> Share

  92. SIMKO F, Reiter RJ
    Is melatonin deficiency a unifying pathomechanism of high risk patients with COVID-19?
    Life Sci. 2020;256:117902.
    >> Share

  93. KHODIR AE, Samra YA, Said E
    A novel role of nifuroxazide in attenuation of sepsis-associated acute lung and myocardial injuries; role of TLR4/NLPR3/IL-1beta signaling interruption.
    Life Sci. 2020 Jun 3:117907. doi: 10.1016/j.lfs.2020.117907.
    >> Share

  94. YAZDANPANAH F, Hamblin MR, Rezaei N
    The immune system and COVID-19: Friend or foe?
    Life Sci. 2020 Jun 2:117900. doi: 10.1016/j.lfs.2020.117900.
    >> Share

  95. PANDEY A, Nikam AN, Shreya AB, Mutalik SP, et al
    Potential therapeutic targets for combating SARS-CoV-2: Drug repurposing, clinical trials and recent advancements.
    Life Sci. 2020 Jun 1:117883. doi: 10.1016/j.lfs.2020.117883.
    >> Share

    May 2020
  96. BANERJEE A, Czinn SJ, Reiter RJ, Blanchard TG, et al
    Crosstalk between endoplasmic reticulum stress and anti-viral activities: A novel therapeutic target for COVID-19.
    Life Sci. 2020;255:117842.
    >> Share

  97. TONG PB, Lin LY, Tran TH
    Coronaviruses pandemics: Can neutralizing antibodies help?
    Life Sci. 2020 May 22:117836. doi: 10.1016/j.lfs.2020.117836.
    >> Share

  98. GURUNG AB, Ali MA, Lee J, Farah MA, et al
    Unravelling lead antiviral phytochemicals for the inhibition of SARS-CoV-2 M(pro) enzyme through in silico approach.
    Life Sci. 2020;255:117831.
    >> Share

  99. RENU K, Prasanna PL, Valsala Gopalakrishnan A
    Coronaviruses pathogenesis, comorbidities and multi-organ damage - A review.
    Life Sci. 2020;255:117839.
    >> Share

  100. MARTIN GIMENEZ VM, Inserra F, Tajer CD, Mariani J, et al
    Lungs as target of COVID-19 infection: Protective common molecular mechanisms of vitamin D and melatonin as a new potential synergistic treatment.
    Life Sci. 2020;254:117808.
    >> Share

  101. KERMALI M, Khalsa RK, Pillai K, Ismail Z, et al
    The role of biomarkers in diagnosis of COVID-19 - A systematic review.
    Life Sci. 2020 May 13:117788. doi: 10.1016/j.lfs.2020.117788.
    >> Share

  102. KERMALI M, Khalsa RK, Pillai K, Ismail Z, et al
    The role of biomarkers in diagnosis of COVID-19 - A systematic review.
    Life Sci. 2020;254:117788.
    >> Share

  103. PATIL VM, Singhal S, Masand N
    A systematic review on use of aminoquinolines for the therapeutic management of COVID-19: Efficacy, safety and clinical trials.
    Life Sci. 2020;254:117775.
    >> Share

  104. POOLADANDA V, Thatikonda S, Godugu C
    The current understanding and potential therapeutic options to combat COVID-19.
    Life Sci. 2020 May 8:117765. doi: 10.1016/j.lfs.2020.117765.
    >> Share

    April 2020
  105. HERRERA EA, Gonzalez-Candia A
    Comment on Melatonin as a potential adjuvant treatment for COVID-19.
    Life Sci. 2020 Apr 30:117739. doi: 10.1016/j.lfs.2020.117739.
    >> Share

  106. BABAPOOR-FARROKHRAN S, Gill D, Walker J, Rasekhi RT, et al
    Myocardial injury and COVID-19: Possible mechanisms.
    Life Sci. 2020;253:117723.
    >> Share

  107. SALLES C
    Correspondence COVID-19: Melatonin as a potential adjuvant treatment.
    Life Sci. 2020 Apr 22:117716. doi: 10.1016/j.lfs.2020.117716.
    >> Share

  108. SHAH B, Modi P, Sagar SR
    In silico studies on therapeutic agents for COVID-19: Drug repurposing approach.
    Life Sci. 2020 Apr 9:117652. doi: 10.1016/j.lfs.2020.117652.
    >> Share

    March 2020
  109. ELFIKY AA
    Ribavirin, Remdesivir, Sofosbuvir, Galidesivir, and Tenofovir against SARS-CoV-2 RNA dependent RNA polymerase (RdRp): A molecular docking study.
    Life Sci. 2020 Mar 25:117592. doi: 10.1016/j.lfs.2020.117592.
    >> Share

    February 2020
  110. ELFIKY AA
    Anti-HCV, nucleotide inhibitors, repurposing against COVID-19.
    Life Sci. 2020 Feb 28:117477. doi: 10.1016/j.lfs.2020.117477.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016